GSK max pain

From the closing options book · October 20, 2026 · updated after every close

GSK's max pain for the October 23, 2026 expiration was 48 at the October 20, 2026 close, −5.2% from GSK's 50.63 close. Max pain is the price at which option holders' total intrinsic value at expiry would be smallest.

48
Max pain
Oct 23 expiry
50.63
Close
−5.2% to max pain
0.24
Put/call OI
0.11
Put/call volume

GSK close vs max pain, last 20 sessions

SessionCloseMax painGap
Oct 2050.6348−5.2%
Oct 1949.4647−5.0%
Oct 1649.5147−5.1%
Oct 1549.0247−4.1%
Oct 1447.8747−1.8%
Oct 1346.2747+1.6%
Oct 1246.9248+2.3%
Oct 946.5048+3.2%
Oct 846.5447+1.0%
Oct 747.0247at the close
Oct 646.6047+0.9%
Oct 546.5547+1.0%
Oct 247.0347.5+1.0%
Oct 147.1849.5+4.9%
Sep 3048.1750+3.8%
Sep 2949.3550+1.3%
Sep 2849.7050+0.6%
Sep 2549.2450+1.5%
Sep 2449.6550+0.7%
Sep 2349.7149.5−0.4%

The session before, max pain sat at 47.

Open interest within 45 days stood at 17,502 calls and 4,285 puts, a put/call ratio of 0.24. On the day, 2,494 calls and 268 puts traded.

Max pain is a property of the open-interest book, not a forecast: price has no obligation to finish there, and on most days it does not. It is most useful as a reference for where the expiring book is balanced.

These are the October 20, 2026 closing numbers. Members see GSK's map move live all session.

Common questions

What is GSK's max pain?

48 for the October 23, 2026 expiration, from open interest at the October 20, 2026 close.

What is GSK's put/call ratio?

By open interest 0.24; by volume 0.11 on October 20, 2026.

Does GSK close at max pain?

Not reliably. Max pain describes where the expiring options book is balanced; it is a reference level, not a prediction.

Compare: max pain on other tickers

Measured from the closing options book and rebuilt after every close. Nothing on this page is live. Levels are where dealer hedging is concentrated, not targets or forecasts. Not investment advice.